Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

With nationwide availability now underway, twiist reaches a meaningful milestone in Sequel’s mission to empower the diabetes community with more choice and a more personalized, customizable AID ...

US-based Sequel Med Tech has introduced its Tidepool-powered twiist automated insulin delivery (AID) system across the country. Following clearance by the US Food and Drug Administration (FDA) in 2024 ...

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.

Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app.

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...